Please select how you are visiting today
Your selection will be remembered. You can change it anytime from the footer.
Stay informed with the latest news, updates, and insights from Medivant Healthcare.
Medivant Healthcare is proud to announce the launch of Andrenyx™ (compounded testosterone cypionate) a single-dose prefilled syringe engineered for precision, sterility, and real-world clinical usability.
Read More
Medivant Healthcare is proud to announce the launch of Andrela™ the first 503B cGMP compounded microdose testosterone cypionate in prefilled syringes. Testosterone therapy is not one-size-fits-all. Individualized dosing at lower therapeutic levels demands a delivery format capable of matching clinical intent exactly — and until now, that format simply didn't exist.
Read More
Medivant Healthcare hosted Congressman Greg Stanton and community leaders at its Chandler facility to discuss strengthening local healthcare manufacturing and workforce development.
Read More
Medivant Healthcare thanks the Chandler Chamber of Commerce for the spotlight and highlights its ongoing commitment to strengthening Chandler’s healthcare and business ecosystem.
Read More
Medivant Healthcare will attend the ASRS 2026 Business of Retina Meeting in Houston, connecting with retinal professionals to support improved patient outcomes and practice efficiency.
Read More
Medivant Healthcare announces its partnership with Angels for Change and the upcoming launch of Lorazepam injectable vials to help address critical drug shortages.
Read More
Medivant Healthcare will attend the HCP Fall 2025 Hospital Pharmacy Conference in Chicago, showcasing solutions to address drug supply challenges and connecting with industry professionals.
Read More
Medivant Healthcare will attend the 2025 Hospital Pharmacy Buyer Conference in Miami, connecting with healthcare professionals and showcasing its latest solutions.
Read More
Medivant Healthcare will be exhibiting at Premier Breakthroughs 2025 in National Harbor, MD, showcasing innovation and connecting with healthcare leaders.
Read More
Medivant Healthcare highlights its scalable, fully automated cGMP sterile injectable manufacturing capabilities designed to improve supply chain reliability and meet growing healthcare demand.
Read More
Medivant Healthcare participated in the Health Connect Partners pharmacy show in Indianapolis, connecting with attendees and showcasing solutions for sterile injectable shortages.
Read More
Medivant Healthcare is addressing injectable drug shortages through U.S.-based manufacturing, automation, and scalable production of sterile generic injectables.
Read More
Medivant Healthcare announces the launch of repackaged Bevacizumab (Avastin) for ophthalmic use, offering precise dosing and consistent quality through automated prefilled syringe technology.
Read More
Medivant Healthcare announces the launch of Bupivacaine with Epinephrine 10 mL vial, a preservative-free formulation designed for reliable and precise anesthesia applications.
Read More
Medivant Healthcare announces the nationwide shipment of Lidocaine 1% with Epinephrine and the release of initial lots totaling 100,000 vials.
Read MoreMedivant Healthcare announces the launch of Lidocaine 1% with Epinephrine 10 mL single-dose vials to help address nationwide shortages.
Read More
Medivant Healthcare invites HCP Las Vegas attendees to visit its hospitality suite for networking, golf simulation, and prize opportunities.
Read More
Medivant Healthcare will attend DCAT Week 2023 in New York City, connecting with partners and showcasing its sterile injectable fill/finish capabilities.
Read More
Medivant Healthcare invites HCP Las Vegas attendees to visit Booth #1112 and connect at its hospitality suite to learn more about its sterile injectable solutions.
Read MoreMedivant Healthcare congratulates Jenny Stone of the University of Arkansas for winning the grand raffle prize at the HCP RX Buyers Summit in Kansas City.
Read More
Medivant Healthcare served as a reverse expo sponsor at the inaugural HCP RX Buyer Summit, supporting collaboration between healthcare providers and suppliers.
Read More
Medivant Healthcare participated in NPPA 2022, connecting with healthcare professionals and showcasing solutions to address sterile drug shortages.
Read More
Medivant Healthcare released multiple lots of sterile water for injection to hospitals across the West and Pacific Northwest to help address acute shortages.
Read MoreMedivant Healthcare announces available supply of Ketamine injection, ready to ship to support healthcare provider needs.
Read More
Medivant Healthcare will attend the IDN Summit in Orlando, showcasing solutions to support hospitals with generic injectable needs while reducing pharmacy spend.
Read More
Medivant Healthcare highlights its commitment to uninterrupted supply through fully automated cGMP manufacturing, delivering high-volume hospital medications efficiently and reliably.
Read More
Medivant Healthcare announces that Lidocaine 2%, manufactured in its Arizona facility, is now shipping to hospitals nationwide.
Read More
Medivant Healthcare announces that Lidocaine 1% 10 mL vials, manufactured in its Arizona facility, are now available to hospitals nationwide.
Read More
Medivant Healthcare announces the release of Lidocaine 4%, now being distributed to hospitals nationwide.
Read More
Medivant Healthcare announces the release of Bupivacaine 0.5%, now available to hospitals nationwide.
Read More
Medivant Healthcare announces that Ketamine 500 mg/5 mL injectable is now shipping to hospitals across the country.
Read MoreMedivant Healthcare highlights its fully automated cGMP manufacturing capabilities, enabling high-volume production of hospital medications with enhanced efficiency and quality.
Read More
Medivant Healthcare announces the availability of Calcium Chloride injectable vials to support hospital supply needs.
Read MoreStay up to date with the latest from Medivant Healthcare
Contact us to receive updates about product availability, new offerings, and important announcements from Medivant Healthcare.
Contact Us